NURS 676 Advanced Pharmacology Midterm Exam (WCU) @Question And Answers
7 views 0 purchase
Course
676 Advanced Pharmacology
Institution
676 Advanced Pharmacology
NURS 676 Advanced Pharmacology Midterm Exam (WCU)
@Question And Answers
What is the first line drug for a patient with hypothyroidism? - ANSLevothyroxine, a thyroid hormone
What is the first line drug for a patient with hyperthryoidism? - ANSMethimazole, an antithyroid agent
What is the firs...
NURS 676 Advanced Pharmacology Midterm Exam (WCU)
@Question And Answers
What is the first line drug for a patient with hypothyroidism? - ANS-
Levothyroxine, a thyroid hormone
What is the first line drug for a patient with hyperthryoidism? - ANS-
Methimazole, an antithyroid agent
What is the first line drug for a pregnant patient with diabetes? -
ANS-Insulins that are rapid or short acting that are hum- derivatives.
What should patients HbA1C levels be below? - ANS-6.5%
Alendronate - ANS-Class: Bisphosphanate used to treat
osteoporosis and Paget's dx
MOA: Inhibits osteoclastic activity, increases bone density.
Tiludronate - ANS-Class: Bisphosphanate used to treat
osteoporosis and Paget's dx
MOA: Inhibits osteoclastic activity, increases bone density.
T or F: Amitriptylline will increase the concentration of
norepinephrine in the synapse - ANS-True
T or F: Haloperidol is a high potency antipsychotic which blocks
dopamine receptors? - ANS-True
T or F: Glipizide inhibits the dipeptidyl peptidase 4 enzyme? - ANS-
False
,T or F: A decreased concentration of TSH is commonly treated with
levothyroxine. - ANS-False
What is one long acting form of insulin? - ANS-Glargine or Detemir
,Lispro - ANS-Class: Rapid acting insulin for hyperglycemia
MOA: Onset 5 minutes; peaks 5 minutes; duration 4-5 hours
Aspart - ANS-Class: Rapid acting insulin for hyperglycemia
MOA: Onset 5 minutes; peaks 5 minutes; duration 4-5 hours
Regular - ANS-Class: Short acting insulin for hyperglycemia
MOA: Onset 30-45 minutes; peaks 3-4 hours; duration 4-10 hours
NPH - ANS-Class: Intermediate insulin for hyperglycemia
MOA: Onset 30 minutes-1 hour; peaks 4-10 hours; duration 12-24
hours
Glargine - ANS-Class: Long acting insulin for hyperglycemia
MOA: Onset 2-4 hours; does not have a peak, duration 24 hours
Detemir - ANS-Class: Long acting insulin for hyperglycemia
MOA: Onset 2-4 hours; does not have a peak, duration 24 hours
Glipizide - ANS-Class: Short acting Sulfonylurea for an insufficient
production of insulin in DM2
MOA: Stimulates insulin release form beta cells, all potentiate
effects of ADH.
Glyburide - ANS-Class: Sulfonylurea for an insufficient production
of insulin in DM2
MOA: Stimulates insulin release form beta cells, all potentiate
effects of ADH.
Chlorpropamide - ANS-Class: Sulfonylurea for an insufficient
production of insulin in DM2; off label for neurogenic DI
MOA: Stimulates insulin release form beta cells, all potentiate
effects of ADH.
, Metformin - ANS-Class: Biguanide, first line drug for DM2
MOA: Decreases glucose production in liver, decreases GI glucose
absorption and improves insulin sensitivity by increasing peripheral
glucose uptake and utilization; does not stimulate insulin release
for beta cells; inhibits platelet aggregation and reduces blood
viscosity.
Acarbose - ANS-Class: Alpha Glucosidase Inhibitor; third-line for
DM2 in insulin resistant patients
MOA: Inhibits absorption of CHO in GI, lowers BG levels after meals
Miglitol - ANS-Class: Alpha Glucosidase Inhibitor; third-line for DM2
in insulin resistant patients
MOA: Inhibits absorption of CHO in GI, lowers BG levels after meals
Sitagliptin - ANS-Class: Dipeptidyl Peptidase 4 Inhibitor for DM2
MOA: Inhibits DPP4, breaks down GLP1 and GIP which are released
in response to a meal; leads to increase in secretion of insulin and
suppresses the release of glucagon by the pancreas; promotes pre
and postprandial glucose levels.
Saxaglipin - ANS-Class: Dipeptidyl Peptidase 4 Inhibitor for DM2
MOA: Inhibits DPP4, breaks down GLP1 and GIP which are released
in response to a meal; leads to increase in secretion of insulin and
suppresses the release of glucagon by the pancreas; promotes pre
and postprandial glucose levels.
Exenatide - ANS-Class: Glucagon Like Peptide 1 Agonist for DM2
MOA: Promotes insulin release from pancreatic beta cells in the
presence of elevated glucose concentrations.
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller laurenjames. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $17.99. You're not tied to anything after your purchase.
